Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iGluco Tech is an Indian medical technology startup focused on revolutionizing diabetes management through non-invasive monitoring. The company has developed iGluco, a portable device that employs near-infrared spectroscopy to measure blood sugar levels without requiring blood samples or skin penetration. The device syncs with a smartphone app to provide users with continuous data visualization and health insights. By eliminating the pain and recurring costs associated with traditional test strips, iGluco Tech seeks to increase compliance and improve long-term outcomes for patients with Type 1 and Type 2 diabetes. The company's technology integrates advanced optical sensors with machine learning algorithms to ensure accuracy across diverse skin types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IGLUCO TECH.